The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression

Abstract

Backgroundβ-Elemene, an effective anticancer component isolated from the Chinese herbal medicine Rhizoma Zedoariae, has been proved to have therapeutic potential against multiple cancers by extensive clinical trials and experimental research. However, its preventive role in cholangiocarcinoma (CCA) and the mechanisms of action of β-elemene on CCA need to be further investigated.MethodsA thioacetamide (TAA)-induced pre-CCA animal model was well-established, and a low dosage of β-elemene was intragastrically (i.g.) administered for 6 months. Livers were harvested and examined histologically by a deep-learning convolutional neural network (CNN). cDNA array was used to analyze the genetic changes of CCA cells following β-elemene treatment. Immunohistochemical methods were applied to detect β-elemene-targeted protein PCDH9 in CCA specimens, and its predictive role was analyzed. β-Elemene treatment at the cellular or animal level was performed to test the effect of this traditional Chinese medicine on CCA cells.ResultsIn the rat model of pre-CCA, the ratio of cholangiolar proliferation lesions was 0.98% ± 0.72% in the control group, significantly higher than that of the β-elemene (0. 47% ± 0.30%) groups (p = 0.0471). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that the top 10 pathways affected by β-elemene treatment were associated with energy metabolism, and one was associated with the cell cycle. β-Elemene inactivated a number of oncogenes and restored the expression of multiple tumor suppressors. PCDH9 is a target of β-elemene and displays an important role in predicting tumor recurrence in CCA patients.ConclusionsThese findings proved that long-term use of β-elemene has the potential to interrupt the progression of CCA and improve the life quality of rats. Moreover, β-elemene exerted its anticancer potential partially by restoring the expression of PCDH9.

Prevalence of inappropriateness of elemene injection for hospitalized cancer patients: a multicenter retrospective study

“…It is unclear whether patients with colorectal cancer could benefit from elemene treatment. Other nonindication uses of elemene, such as in pancreatic carcinoma and biliary tract cancer, have only been investigated in in vitro studies (Long et al, 2019;Wu et al, 2022). These findings indicated that efforts to reduce elemene use in patients without suitable indications should be made preferentially.…”

Emerging roles for the RXFP1 in myeloid series leukemia

“…Through activating GSK-3β, PCDH9 prevents cell migration and the epithelial-mesenchymal transition in hepatocellular cancer (9). PCDH9 interacts with DNMT1, activated DNMT1 suppresses CDH2 and inhibit cancer metastasis (10).As a member of the epidermal growth factor (EGF) family, amphiregulin (AREG) is expressed in many different types of neoplasms, such as pancreatic, ovarian, breast, bladder, colon, and lung malignancies (11). Through the EGFR/PI3K/Akt/NF-κB signaling pathway, AREG increased the expression of ICAM-1 and accelerated cancer cell motility in osteosarcoma.…”

Identification of New Genes and Genetic Variant Loci Associated with Breast Muscle Development in the Mini-Cobb F2 Chicken Population Using a Genome-Wide Association Study

“…Protocadherin 9 ( PCDH9 ) encodes a member of the protocadherin family, and cadherin superfamily, of transmembrane proteins containing cadherin domains. In some human diseases, PCDH9 is negatively correlated with the proliferation and apoptosis of tumor cells [ 49 ] and is also a target of some anticancer molecules [ 50 ]. In mouse nerves, PCDH9 is involved in the formation of specific neural circuits [ 51 ], while in chickens, only a specific spatiotemporal expression pattern of PCDH9 was found in chick’s embryonic spinal cords, suggesting that it can affect the development of the spinal cord and its surrounding tissues [ 52 ].…”